Evidence map›Paper›PMID 30230953›Full record

SynthesisHuman vaccines & immunotherapeutics2019

Vaccination herd effect experience in Latin America: a systematic literature review.

Rodrigo DeAntonio, Sylvia Amador, Eveline M Bunge, Jennifer Eeuwijk, David Prado-Cohrs, Javier Nieto Guevara, Maria Del Pilar Rubio, Eduardo Ortega-Barria

Abstract readSystematic Review
In one paragraph

Synthesis in Human vaccines & immunotherapeutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. [Ranking of immunization programs in Latin America, 2020Revista panamericana de salud publica = Pan American journal of public health · 2024
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rodrigo DeAntonioa Centro de Vacunación Internacional S A CEVAXIN , Panama City , Panama.ORCID 0000-0003-2586-4115
Sylvia Amadorb GSK , Panama City , Panama.
Eveline M Bungec Pallas Health Research and Consultancy BV , Rotterdam , the Netherlands.
Jennifer Eeuwijkc Pallas Health Research and Consultancy BV , Rotterdam , the Netherlands.ORCID 0000-0003-4488-5157
David Prado-Cohrsd GSK , Guatemala City , Guatemala.
Javier Nieto Guevarab GSK , Panama City , Panama.
Maria Del Pilar Rubioe GSK , Bogota Corporate Center , Bogotá , D.C. , Colombia.
Eduardo Ortega-Barriab GSK , Panama City , Panama.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNational pediatric vaccination programs have been introduced in Latin America (LatAm) to reduce the burden of diseases due to pathogens such as rotavirus, Haemophilus influenzae type b (Hib) and pneumococcus. Vaccination health benefits may extend to unvaccinated populations by reducing pathogen transmission. Understanding herd effect is important for implementation and assessment of vaccination programs. The objective was to conduct a systematic review of published epidemiological evidence of herd effect with Hib, rotavirus and pneumococcal conjugate vaccines (PCV) in LatAm.

methodsSearches were conducted in PubMed, Virtual Health Library (VHL), SciELO and SCOPUS databases, for studies reporting data on herd effect from Hib, rotavirus and PCV vaccination in LatAm, without age restriction. Searches were limited to articles published in English, Spanish or Portuguese (1990-2016). After screening and full-text review, articles meeting the selection criteria were included to be critically appraised following criteria for observational and interventional studies. The presence of a herd effect was defined as a significant decrease in incidence of disease, hospitalization, or mortality.

results3,465 unique articles were identified, and 23 were included (Hib vaccine n = 5, PCV n = 8, rotavirus vaccine n = 10). Most studies included children and/or adolescents (age range varied between studies). Studies in adults, including older adults (aged > 65 years), were limited. Few studies reported statistically significant reductions in disease incidence in age groups not targeted for vaccination. Hib-confirmed meningitis hospitalization decreased in children but herd effect could not be quantified. Some evidence of herd effect was identified for PCV and rotavirus vaccine in unvaccinated children. Evidence for herd effects due to PCV in adults was limited.

conclusionAfter introduction of Hib, PCV and rotavirus vaccination in LatAm, reductions in morbidity/mortality have been reported in children not targeted for vaccination. However, due to methodological limitations (e.g. short post-vaccination periods and age range studied), there is currently insufficient evidence to quantify the herd effect in adult populations. More research and higher quality surveillance is needed to characterize herd effect of these vaccines in LatAm.

Indexed as

Immunity, HerdImmunization ProgramsVaccinationBacterial CapsulesHaemophilus VaccinesHumansLatin AmericaPneumococcal VaccinesRotavirus VaccinesHaemophilus influenzae type b polysaccharide vaccineHaemophilus VaccinesPneumococcal VaccinesRotavirus Vaccinesherd effectLatin Americapneumococcal conjugate vaccinerotavirus vaccinesystematic reviewtype b (Hib) vaccine

Identifiers

PMID30230953
PMCPMC6363147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.